|
|
||||||||
The FASEB Journal, Vol 11, 683-694, Copyright © 1997 by The Federation of American Societies for Experimental Biology
RESEARCH COMMUNICATIONS |
T Eschenhagen, C Fink, U Remmers, H Scholz, J Wattchow, J Weil, W Zimmermann, HH Dohmen, H Schafer, N Bishopric, T Wakatsuki and EL Elson
Abteilung Allgemeine Pharmakologie, Universitats-Krankenhaus Eppendorf, Universitat Hamburg, Germany.
A method has been developed for culturing cardiac myocytes in a collagen matrix to produce a coherently contracting 3-dimensional model heart tissue that allows direct measurement of isometric contractile force. Embryonic chick cardiomyocytes were mixed with collagen solution and allowed to gel between two Velcro-coated glass tubes. During culture, the cardiomyocytes formed spontaneously beating cardiac myocyte-populated matrices (CMPMs) anchored at opposite ends to the Velcro-covered tubes through which they could be attached to a force measuring system. Immunohistochemistry and electron microscopy revealed a highly organized tissue-like structure of alpha-actin and alpha- tropomyosin-positive cardiac myocytes exhibiting typical cross- striation, sarcomeric myofilaments, intercalated discs, desmosomes, and tight junctions. Force measurements of paced or unpaced CMPMs were performed in organ baths after 6-11 days of cultivation and were stable for up to 24 h. Force increased with frequency between 0.8 and 2.0 Hz (positive "staircase"), increasing rest length (Starling mechanism), and increasing extracellular calcium. The utility of this system as a test bed for genetic manipulation was demonstrated by infecting the CMPMs with a recombinant beta-galactosidase-carrying adenovirus. Transduction efficiency increased from about 5% (MOI 0.1) to about 50% (MOI 100). CMPMs display more physiological characteristics of intact heart tissue than monolayer cultures. This approach, simpler and faster than generation of transgenic animals, should allow functional consequences of genetic or pharmacological manipulation of cardiomyocytes in vitro to be studied under highly controlled conditions.
This article has been cited by other articles:
![]() |
A. N. Morritt, S. K. Bortolotto, R. J. Dilley, X. Han, A. R. Kompa, D. McCombe, C. E. Wright, S. Itescu, J. A. Angus, and W. A. Morrison Cardiac Tissue Engineering in an In Vivo Vascularized Chamber Circulation, January 23, 2007; 115(3): 353 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Asnes, J. P. Marquez, E. L. Elson, and T. Wakatsuki Reconstitution of the Frank-Starling Mechanism in Engineered Heart Tissues Biophys. J., September 1, 2006; 91(5): 1800 - 1810. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-H. Zimmermann, M. Didie, S. Doker, I. Melnychenko, H. Naito, C. Rogge, M. Tiburcy, and T. Eschenhagen Heart muscle engineering: An update on cardiac muscle replacement therapy Cardiovasc Res, August 1, 2006; 71(3): 419 - 429. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Naito, I. Melnychenko, M. Didie, K. Schneiderbanger, P. Schubert, S. Rosenkranz, T. Eschenhagen, and W.-H. Zimmermann Optimizing Engineered Heart Tissue for Therapeutic Applications as Surrogate Heart Muscle Circulation, July 4, 2006; 114(1_suppl): I-72 - I-78. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-M. Guo, Y.-S. Zhao, H.-X. Chang, C.-Y. Wang, L.-L. E, X.-A. Zhang, C.-M. Duan, L.-Z. Dong, H. Jiang, J. Li, et al. Creation of Engineered Cardiac Tissue In Vitro From Mouse Embryonic Stem Cells Circulation, May 9, 2006; 113(18): 2229 - 2237. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Eschenhagen and W. H. Zimmermann Engineering Myocardial Tissue Circ. Res., December 9, 2005; 97(12): 1220 - 1231. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bartholoma, E. Gorjup, D. Monz, A. Reininger-Mack, H. Thielecke, and A. Robitzki Three-Dimensional In Vitro Reaggregates of Embryonic Cardiomyocytes: A Potential Model System for Monitoring Effects of Bioactive Agents J Biomol Screen, December 1, 2005; 10(8): 814 - 822. [Abstract] [PDF] |
||||
![]() |
O. Ishii, M. Shin, T. Sueda, and J. P. Vacanti In vitro tissue engineering of a cardiac graft using a degradable scaffold with an extracellular matrix-like topography J. Thorac. Cardiovasc. Surg., November 1, 2005; 130(5): 1358 - 1363. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Baar New dimensions in tissue engineering: possible models for human physiology Exp Physiol, November 1, 2005; 90(6): 799 - 806. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Radisic, H. Park, H. Shing, T. Consi, F. J. Schoen, R. Langer, L. E. Freed, and G. Vunjak-Novakovic From the Cover: Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds PNAS, December 28, 2004; 101(52): 18129 - 18134. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Heng, H. K. Haider, E. K.-W. Sim, T. Cao, and S. C. Ng Strategies for directing the differentiation of stem cells into the cardiomyogenic lineage in vitro Cardiovasc Res, April 1, 2004; 62(1): 34 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Vasavada, J. R. DiAngelo, and M. K. Duncan Developmental Expression of Pop1/Bves J. Histochem. Cytochem., March 1, 2004; 52(3): 371 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Radisic, L. Yang, J. Boublik, R. J. Cohen, R. Langer, L. E. Freed, and G. Vunjak-Novakovic Medium perfusion enables engineering of compact and contractile cardiac tissue Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H507 - H516. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Evans, J. K. Sweet, R. L. Price, M. Yost, and R. L. Goodwin Novel 3D culture system for study of cardiac myocyte development Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H570 - H578. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wiechert, A. El-Armouche, T. Rau, W. -H. Zimmermann, and T. Eschenhagen 24-h Langendorff-perfused neonatal rat heart used to study the impact of adenoviral gene transfer Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H907 - H914. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Akhyari, P. W. M. Fedak, R. D. Weisel, T.-Y. J. Lee, S. Verma, D. A. G. Mickle, and R.-K. Li Mechanical Stretch Regimen Enhances the Formation of Bioengineered Autologous Cardiac Muscle Grafts Circulation, September 24, 2002; 106(12_suppl_1): I-137 - I-142. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-H. Zimmermann, M. Didie, G. H. Wasmeier, U. Nixdorff, A. Hess, I. Melnychenko, O. Boy, W. L. Neuhuber, M. Weyand, and T. Eschenhagen Cardiac Grafting of Engineered Heart Tissue in Syngenic Rats Circulation, September 24, 2002; 106(12_suppl_1): I-151 - I-157. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kofidis, P. Akhyari, B. Wachsmann, J. Boublik, K. Mueller-Stahl, R. Leyh, S. Fischer, and A. Haverich A novel bioartificial myocardial tissue and its prospective use in cardiac surgery Eur. J. Cardiothorac. Surg., August 1, 2002; 22(2): 238 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kofidis, P. Akhyari, J. Boublik, P. Theodorou, U. Martin, A. Ruhparwar, S. Fischer, T. Eschenhagen, H. P. Kubis, T. Kraft, et al. In vitro engineering of heart muscle: Artificial myocardial tissue J. Thorac. Cardiovasc. Surg., July 1, 2002; 124(1): 63 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Akins Can Tissue Engineering Mend Broken Hearts? Circ. Res., February 8, 2002; 90(2): 120 - 122. [Full Text] [PDF] |
||||
![]() |
P. Most, J. Bernotat, P. Ehlermann, S. T. Pleger, M. Reppel, M. Borries, F. Niroomand, B. Pieske, P. M. L. Janssen, T. Eschenhagen, et al. S100A1: A regulator of myocardial contractility PNAS, November 20, 2001; 98(24): 13889 - 13894. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Guccione, S. M. Moonly, A. W. Wallace, and M. B. Ratcliffe Residual stress produced by ventricular volume reduction surgery has little effect on ventricular function and mechanics: A finite element model study J. Thorac. Cardiovasc. Surg., September 1, 2001; 122(3): 592 - 599. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Papadaki, N. Bursac, R. Langer, J. Merok, G. Vunjak-Novakovic, and L. E. Freed Tissue engineering of functional cardiac muscle: molecular, structural, and electrophysiological studies Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H168 - H178. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. FINK, S. ERGÜN, D. KRALISCH, U. REMMERS, J. WEIL, and T. ESCHENHAGEN Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement FASEB J, April 1, 2000; 14(5): 669 - 679. [Abstract] [Full Text] |
||||
![]() |
R.-K. Li, T. M. Yau, R. D. Weisel, D. A.G. Mickle, T. Sakai, A. Choi, and Z.-Q. Jia CONSTRUCTION OF A BIOENGINEERED CARDIAC GRAFT J. Thorac. Cardiovasc. Surg., February 1, 2000; 119(2): 368 - 375. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bursac, M. Papadaki, R. J. Cohen, F. J. Schoen, S. R. Eisenberg, R. Carrier, G. Vunjak-Novakovic, and L. E. Freed Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies Am J Physiol Heart Circ Physiol, August 1, 1999; 277(2): H433 - H444. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-H. Zimmermann, K. Schneiderbanger, P. Schubert, M. Didie, F. Munzel, J.F. Heubach, S. Kostin, W.L. Neuhuber, and T. Eschenhagen Tissue Engineering of a Differentiated Cardiac Muscle Construct Circ. Res., February 8, 2002; 90(2): 223 - 230. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shimizu, M. Yamato, Y. Isoi, T. Akutsu, T. Setomaru, K. Abe, A. Kikuchi, M. Umezu, and T. Okano Fabrication of Pulsatile Cardiac Tissue Grafts Using a Novel 3-Dimensional Cell Sheet Manipulation Technique and Temperature-Responsive Cell Culture Surfaces Circ. Res., February 22, 2002; 90(3): e40 - 48. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |